Screening for Esophageal Cancer
Journal of Gastroenterology and Hepatology · 2026
DOI: 10.1111/jgh.70196 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Eugene Phan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Lyell McEwin Hospital, Elizabeth Vale, South Australia, Australia. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Early Detection of Cancer, Adenocarcinoma, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 75 Literaturangaben.
Abstract (Originalsprache)
Esophageal cancer remains a global health burden with poor survival, largely due to late diagnosis. The two main subtypes—esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC)—differ in their epidemiology, risk factors, and geographic distribution, highlighting the importance of region‐specific screening. In areas with a high incidence of ESCC, population‐based endoscopic screening has improved early detection and outcomes. In contrast, in Western countries where EAC predominates, targeted screening for Barrett's esophagus (BE) offers the most practical approach. Advances in high‐definition endoscopy, virtual chromoendoscopy, and minimally invasive resection have enhanced diagnostic precision and treatment efficacy. At the same time, novel nonendoscopic methods such as swallowable devices, biomarker assays, and artificial intelligence–assisted imaging are reshaping screening paradigms. This review outlines current and emerging strategies for early detection of ESCC and EAC, emphasizing technological innovation and its potential to improve global outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Lyell McEwin Hospital, Elizabeth Vale, South Australia, Australia.
- School of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia.
- Department of Medical Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
- Preemptive Medicine and Lifestyle Disease Research Center, Kyoto University Hospital, Kyoto, Japan.
- Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
ORCID-Profile: Shinya Ohashi, Edward Young, Sakiko Naito
Zitieren
APA
Phan, E., Ohashi, S., Singh, A. P., Young, E., Katada, C., Naito, S., Ueda, A., Muto, M., & Singh, R. (2026). Screening for Esophageal Cancer. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70196
Vancouver
Phan E, Ohashi S, Singh AP, Young E, Katada C, Naito S, et al. Screening for Esophageal Cancer. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70196
BibTeX
@article{Phan2026,
author = {Phan, Eugene and Ohashi, Shinya and Singh, Amitjeet Phajneek and Young, Edward and Katada, Chikatoshi and Naito, Sakiko and Ueda, Aya and Muto, Manabu and Singh, Rajvinder},
title = {Screening for Esophageal Cancer},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70196}
}
EUVIMED